Division News

In 2012, as John Perfect, MD, studied the inner workings of the genes of Cryptococcus neoformans, a fungus that infects humans and kill 600,000 people a year, he realized he was only looking at half of a problem. “There is always two sides to an infection—the pathogen and the host,” said Dr.

Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine. The findings, published March 18, 2014, in the journal PLOS ONE, provide the most comprehensive look at bloodstream infections in community hospitals to date.

Ephraim Tsalik, MD, PhD, assistant professor of medicine (Infectious Diseases), has been selected to serve as an associate scientific advisor for Science’s sister journal, Science Translational Medicine. "Dr. Tsalik is an excellent choice for this," said Geoffrey Ginsburg, MD, PhD, professor of medicine (Cardiology) and pathology and director of genomic medicine at the Duke Institute for Genome Sciences & Policy. Dr.

A snapshot of patients who required care at Duke University Hospital during this year’s flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment. In an analysis of the first 55 patients treated for flu at the academic medical center from November 2013 through Jan. 8, 2014, Duke Medicine researchers found that only two of the 22 patients who required intensive care had been vaccinated prior to getting sick. The findings were published online in Mon., Feb.

[caption id="attachment_14288" align="alignright" width="210"] Deverick J. Anderson, MD, MPH[/caption] Deverick Anderson, MD, MPH, got an unusual phone call last August.

Medicine Grand Rounds on Fri., Dec. 6 at 8 a.m. in Duke Hospital room 2002 will feature David Holland, MD, MHS, assistant professor of medicine (Infectious  Diseases and International Health). Dr.

The Duke Center for Genomics of Microbial Systems (GeMS) is in the process of developing a new service for sequencing-based analysis of complex microbial communities. In response to increasing demand for microbiome analysis from investigators across the Duke campus, the GeMS Bioinformatics Group (Josh Granek, PhD, and Olaf Mueller, PhD) together with several GeMS faculty (Lawrence David, PhD;

The Medicine Research Conference returns Fri., Oct. 25 at 12 p.m. in Duke Hospital 2002 with a presentation by Mary E. Klotman, MD, chair of the Department of Medicine and RJ Reynolds Professor of Medicine (Infectious Diseases). Dr. Klotman will present HIV and the Kidney: From Mice to Men. Lunch will be provided.

A blood test developed by researchers at Duke Medicine – including Geoffrey Ginsburg, Aimee Zaas and Christopher Woods – showed more than 90-percent accuracy in distinguishing between viral and bacterial infections when tested in people with respiratory illnesses. This research was covered by multiple media outlets yesterday, including this Washington Post article:&nb

The Duke CustomID is a decision support tool intended to provide clinicians with institution-specific, easily accessible, easily customizable information about the diagnosis and treatment of infectious diseases inside of the Duke institution.